Treatment of steroid-resistant systemic lupus erythematosus with extremely low dose of cyclosporine A

Pediatrics International

Volumn 46, Issue 4, 2004, Pages 468-470

  Sakano, Takashi ^a   Ohta, Toshiyuki ^a   Kinoshita, Yoshihisa ^a   Fjiwara, Mami ^a   Wakai, Mari ^a  

^a HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

Author keywords

Cyclosporine A; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LIVER ENZYME; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; STEROID;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG PULSE THERAPY; FEMALE; HAIR LOSS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LABORATORY TEST; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL;

CHILD; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; STEROIDS; TREATMENT OUTCOME;

EID: 4344664004     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2004.01918.x     Document Type: Article

References (10)

1. Caccavo D, Laganà B, Mitterhofer AP et al. Long-term treatment of systemic lupus erythematosus with cyclosporin A. Arthritis Rheum. 1997; 40: 27-35.
2. Radhakrishnan J, Kunis CL, D'Agati V, Appel GB. Cyclosporine treatment of lupus membranous nephropathy. Clin. Nephrol. 1994; 42: 147-54.
3. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Committee on prognosis studies in SLE. Derivation of the SLEDAI. Arthritis Rheum. 1992; 35: 630-40.
4. Ambalavanan S, Fauvel JP, Sibley RK, Myers BD. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J. Am. Soc. Nephrol. 1996; 7: 290-8.
5. Sugiyama M, Ogasawara H, Kaneko H et al. Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus. Lupus 1998; 7: 53-6.
6. Maillefert JF, Maynadie M, Tebib JG et al. Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br. J. Rhuematol. 1996; 35: 430-5.
7. Barama AA, Yilmaz S, Gough J et al. Lower cyclosporine exposure increases the risk for sub-clinical rejection in renal transplant recipients. Transplantation 2000; 69 (Suppl. 8): S225.
8. Mahalati K, Belitsky P, Kiberd B et al. Absorption profiling - a novel method for monitoring neoral in kidney transplantation that reduces rejection and nephrotoxicity. Transplantation 2000; 69 (Suppl. 8): S114.
9. Qien RM, Kaiser BA, Dunn SP et al. Calcineurin activity in children with renal transplants receiving cyclosporine. Transplantation 1997; 64: 1486-9.
10. Sindhi R, LaVia MF, Paulling E et al. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine + rapamaycin regimen. Transplantation 2000; 69: 432-6.